文献速递神经肿瘤

内镜治疗巨大垂体腺瘤:205例临床结果与两种术前预测切除程度分类系统的比较

Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection.
PubMed 文献 · J Neurosurg · 2021-09-17

该回顾性研究纳入205例接受内镜经鼻蝶手术的巨大垂体腺瘤患者,平均年龄46.95岁,平均术前肿瘤直径46.56 mm。全切除(GTR)率35.12%,近全切除(NTR)率39.51%,次全切除(STR)率25.36%。两种分类系统的分级和分区与切除程度显著相关(p < 0.001),Grade 3和Zone 3均提示切除程度有限。2017年后采用旨在最大化切除和包膜剥离的手术策略,GTR率从27.05%升至40.83%,术后卒中从7例降至1例。

要点

  • 巨大垂体腺瘤内镜下GTR率为35.12%,NTR率为39.51%,STR率为25.36%。
  • Grade 3和Zone 3肿瘤切除程度有限,STR率分别为75.75%和65.75%。
  • 2017年后强化包膜剥离策略使GTR率由27.05%升至40.83%,术后卒中减少。

核心结论

  • 包膜剥离和GTR有助于预防严重并发症并减少巨大腺瘤复发。
  • 基于术前预测切除程度的分类系统有助于管理巨大垂体腺瘤的内镜治疗。

研究设计与样本

  • 回顾性纳入1997年8月至2019年12月接受内镜经鼻蝶手术的巨大垂体腺瘤患者205例。
  • 平均年龄46.95岁,平均术前肿瘤直径46.56 mm,平均随访50.16个月(范围9-247个月)。
  • 基于肿瘤特征制定形态学评分,基于神经血管标志划分手术分区,构建两种分类系统。
  • 比较2017年前后手术策略改变对切除率和并发症的影响。

主要发现

  • GTR率35.12%,NTR率39.51%,STR率25.36%。
  • 分类系统的分级和分区与切除程度显著相关(p < 0.001)。
  • Grade 3肿瘤中STR占75.75%,NTR占21.21%,GTR占3.03%。
  • Zone 3肿瘤中STR占65.75%,NTR占32.87%,GTR占1.36%。
  • 术后至少一个激素轴恢复者占垂体功能低下患者的15.24%,新发激素缺乏占22.43%。

临床怎么用

  • 术前可采用形态学评分或基于标志的分区分类预测巨大垂体腺瘤的内镜切除程度。
  • Grade 3或Zone 3肿瘤应预期切除程度有限,需充分告知患者。
  • 采用包膜剥离和追求GTR的策略可能提高切除率并降低术后卒中风险。

局限性

  • 回顾性单中心研究,分类系统需外部验证。
  • 2017年前后比较为历史对照,可能存在时间偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Giant pituitary adenoma is considered a challenging pathology for surgery owing to its complications and low resection rate. In this study, the authors present their experience of using the endoscopic endonasal approach to treat patients with giant pituitary adenoma, and they aimed to develop a classification system for prediction of extent of resection. METHODS: The institutional medical records of patients diagnosed with giant pituitary adenoma who underwent endoscopic endonasal transsphenoidal surgery between August 1997 and December 2019 were retrospectively reviewed. Surgical and clinical outcomes were evaluated in detail. The effects of tumor characteristics on extent of resection were analyzed. The findings were used to develop two classification systems that could preoperatively predict extent of resection. Morphological score was based on tumor characteristics, and landmark-based classification was defined according to surgical zones based on neurovascular landmarks. The effects of change in surgical strategy, which aimed to maximize tumor resection and capsule dissection, on rates of resection and complications were evaluated before and after 2017. RESULTS: This study included 205 patients, with a mean patient age of 46.95 years and mean preoperative tumor diameter of 46.56 mm. Gross-total resection (GTR) was achieved in 35.12% of patients, near-total resection (NTR) in 39.51%, and subtotal resection (STR) in 25.36%. Extent of resection differed significantly between the grades and zones of the classification systems (p < 0.001 for both). Among patients with grade 3 tumor, 75.75% of patients achieved STR, 21.21% achieved NTR, and 3.03% achieved GTR. Among patients with zone 3 tumor, 65.75% achieved STR, 32.87% achieved NTR, and 1.36% achieved GTR. Both grade 3 and zone 3 indicated limited extent of resection. The mean (range) follow-up duration was 50.16 (9-247) months. Postoperative recovery of at least one hormone axis was seen in 15.24% of patients with pituitary deficiency, and development of new hormonal deficiency was observed in 22.43% of patients. Complications included permanent diabetes insipidus (7.80%), cerebrospinal fluid leakage (3.90%), postoperative apoplexy (3.90%), meningitis (3.41%), and epistaxis (3.41%). The surgical mortality rate was 1.46%. Among 85 patients treated before 2017, 27.05% of patients achieved GTR, 37.64% achieved NTR, and 35.29% achieved STR; among 120 patients treated after 2017, 40.83% achieved GTR, 40.83% achieved NTR, and 18.33% achieved STR. Seven patients in the pre-2017 cohort had postoperative apoplexy versus only 1 patient in the post-2017 cohort. There were no statistically significant differences between the two periods in terms of the incidence rates of other complications. CONCLUSIONS: Capsule dissection and GTR are valuable for preventing serious complications and reducing recurrence of giant adenoma. Treatment of giant pituitary adenoma may be better managed with the help of a classification system that provides information about extent of resection that can be achieved with an endoscopic approach.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Ceylan S, Sen HE, Ozsoy B, et al. Endoscopic approach for giant pituitary adenoma: clinical outcomes of 205 patients and comparison of two proposed classification systems for preoperative prediction of extent of resection. J Neurosurg. 2021. PMID: 34534953. doi:10.3171/2021.3.JNS204116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。